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1  | INTRODUC TION
Periodontal disease is among the most prevalent human diseases 
with a prevalence of about 796 million affected adults world-
wide (James et al., 2018). Furthermore, periodontitis is regarded 
to be the most common cause for tooth loss (Tonetti, Jepsen, 
Jin, & Otomo-Corgel, 2017) and a limitation of oral health-re-
lated quality of life (Buset et al., 2016; Kinane, Stathopoulou, & 
Papapanou, 2017).
While the first and foremost aim of any periodontal treat-
ment is to resolve dysbiotic microbial communities in subgingival 
plaque and the concomitant periodontal inflammation (Bostanci 
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Abstract
Aim: To investigate tooth survival and clinical long-term outcomes up to 26 years fol-
lowing guided tissue regeneration (GTR) therapy in deep intra-bony defects.
Methods: Patients from three prospective clinical split-mouth studies, which inves-
tigated the outcomes of GTR therapy, were re-evaluated 21–26 years after surgery 
independent of the membrane type used, and tooth survival was assessed according 
to several site-specific and patient-related factors.
Results: About 50 patients contributing 102 defects were available for this long-term 
follow-up. After up to 26 years (median 23.3 years), 52.9% of the teeth were still in 
situ. The median survival of the extracted teeth was 13.8 years. Patients with dia-
betes mellitus and/or smoking history lost significantly more teeth in the long term. 
Compared to the 1-year situation, there was no new median CAL loss after up to 
26 years in the teeth which were still in situ.
Conclusions: Within the limitations of this study, our data show that more than 50% 
of the initially seriously diseased teeth were still in situ up to 26 years following GTR 
therapy despite an overall limited adherence to SPT. In the majority of these teeth, 
the CAL gain 1 year after GTR could be maintained over this long period.
K E Y W O R D S
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& Belibasakis, 2017), regeneration of the lost periodontal tissues 
in terms of reconstitution of their original architecture and func-
tion represents the ultimate challenge in clinical periodontology 
(Cortellini & Tonetti, 2015; Sallum, Ribeiro, Ruiz, & Sallum, 2019). 
In this context, guided tissue regeneration (GTR) and the use of 
enamel matrix derivatives are scientifically accepted and clinically 
available treatment concepts for predictive regenerative periodon-
tal therapy in deep intra-bony periodontal defects (Cortellini & 
Tonetti, 2015; Kao, Nares, & Reynolds, 2015; Reynolds et al., 2015; 
Sallum et al., 2019; Wu, Lin, Song, Su, & Tu, 2017). GTR therapy is 
based on the use of cell-occlusive barrier membranes that prevent 
down-growth of epithelial cells along the root surface and maintain 
a protected space within the periodontal defect that allows for pro-
liferation of the slowly migrating periodontal ligament (PDL) cells 
(Karring, Nyman, Gottlow, & Laurell, 1993; Larsson et al., 2016; 
Sallum et al., 2019). While conventional non-surgical or surgical 
periodontal treatment approaches result in the formation of a 
long-junctional epithelium as a reparative tissue, numerous histo-
logical studies demonstrated regeneration of PDL, cementum and 
alveolar bone following GTR therapy (Karring et al., 1993; Larsson 
et al., 2016; Sallum et al., 2019).
Clinical outcomes after regenerative periodontal therapy still 
exhibit high variability due to several factors, which can either be 
related to the individual patient, the defect or the surgical tech-
nique used (Cortellini & Tonetti, 2000, 2015). This may particularly 
hold true for GTR, which is known to be a technically sensitive and 
highly demanding technique (Bashutski, Oh, Chan, & Wang, 2011; 
Cortellini & Tonetti, 2015; Sallum et al., 2019). As GTR therapy is a 
very complex and also rather cost-intensive procedure, clinical data 
on its long-term efficacy are desirable for sufficient information 
of patients and healthcare providers (Cortellini, Buti, Pini Prato, & 
Tonetti, 2017; Elangovan, 2016).
Consequently, the aim of this study was to perform a follow-up 
examination of three randomized controlled clinical trials, which had 
been carried out between 1992 and 1996 and examined the clinical 
healing results following GTR in deep intra-bony periodontal defects 
with different types of barrier membranes (Christgau et al., 2002; 
Christgau, Bader, Schmalz, Hiller, & Wenzel, 1998). In particular, the 
present study focused on investigating tooth survival and long-term 
treatment outcomes up to 26 years following GTR therapy in gen-
eral, independent of the membrane type used.
2  | MATERIAL AND METHODS
2.1 | Study design
The present study is a follow-up investigation of three controlled 
randomized prospective clinical split-mouth studies (Christgau et al., 
2002; Christgau et al., 1998) and investigates the long-term out-
comes up to 26 years following GTR therapy. These original studies 
investigated the clinical performance of
• non-resorbable expanded polytetrafluoroethylene membranes 
(ePTFE; Gore-Tex Periodontal Material, W.L. Gore & Associates 
Inc., Flagstaff, AZ, USA) compared to resorbable Polyglactin-910 
membranes (PG-910; Vicryl-Netz Parodontal-Zuschnitt, Ethicon, 
Norderstedt, Germany; study 1; Christgau, Schmalz, Reich, & 
Wenzel, 1995),
• polylactic acid membranes (PLA; Guidor bioabsorbable matrix 
barrier, Guidor AB, Huddinge, Sweden) compared to PG-910 
membranes (Vicryl-Netz Parodontal-Zuschnitt; study 2; Christgau 
et al., 1998) or
• experimental polydioxanone membranes (PDS; Mempol, Ethicon) 
compared to PLA membranes (Guidor bioabsorbable matrix bar-
rier; study 3; Christgau et al., 2002).
Due to non-avoidable drop outs, the original split-mouth design 
and the comparison between different membrane types could not 
be followed in the present follow-up. Instead, the focus was set on 
tooth survival and long-term stability of the attachment gain fol-
lowing GTR therapy in general, independent of the membrane type 
used. The present study design was approved by the ethics com-
mittee of the University of Regensburg (reference: 18-897-101) in 
accordance with the 1964 Helsinki Declaration and its later amend-
ments and comparable ethical standards. After detailed description 
of the proposed clinical examinations, written informed consent was 
obtained from each individual participant included in this follow-up.
2.2 | Patient population
The three studies included in this follow-up originally comprised 
74 patients that had been recruited from the patient pool of the 
Department of Conservative Dentistry and Periodontology of the 
University Hospital Regensburg (Germany). For inclusion in the 
original studies (Christgau et al., 1995, 1998, 2002), all patients had 
Clinical Relevance
Scientific rationale for the study: To investigate the long-
term outcomes up to 26 years after GTR therapy in deep 
intra-bony defects.
Principal findings: In teeth, which survived, the 1-year CAL 
gain remained stable. However, almost 50% of the teeth 
were lost most probably due to an irregular and insufficient 
SPT. Diabetics and smokers showed significantly less tooth 
survival.
Practical implications: Our data indicate that regenerated 
tissue can be maintained over a very long period of time. 
However, the implementation of an adequate SPT and con-
trol of the known risk factors smoking and diabetes seem 
to be crucial in those patients.
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to have a pair of contra-lateral deep interproximal intra-bony peri-
odontal defects with a probing pocket depth (PPD) of at least 6 mm 
and radiographic evidence of angular bone loss of at least 4 mm at 
baseline. Full-mouth supra- and subgingival scaling and root plan-
ing as well as splinting of highly mobile teeth had to be successfully 
completed at least 4–6 weeks before surgery. For inclusion in this 
follow-up, patients had to have received the intended treatment 
and successfully completed clinical examinations at baseline as well 
as after 1 year. Only defects without any furcation involvement at 
baseline were included in this follow-up.
2.3 | Clinical therapeutic procedures
All surgical interventions were performed by one experienced sur-
geon (MC) according to the principles of GTR therapy between 
April 1992 and December 1996 and have been described in de-
tail in the respective original publications (Christgau et al., 1995, 
1998, 2002). Thus, only a brief summary is given here, as follows: 
buccal and oral mucoperiosteal flaps were elevated after sulcular 
incisions. Vertical releasing incisions were avoided in order not to 
interfere with the flap vascularization. Subsequently, a thorough 
defect debridement was performed. The surgical sites in each pa-
tient were randomized for treatment with one of the two different 
barrier membranes in the respective study. The barrier mem-
branes were adjusted to the individual defect morphology, and the 
surgical sites were closed tension-free by coronally repositioned 
flaps to ensure primary membrane coverage. In the case of the 
non-resorbable ePTFE membranes, a second surgical procedure 
was performed after 4–6 weeks for membrane removal. For peri-
operative infection prophylaxis, systemic antibiotic therapy was 
performed (studies 1 and 2 [Christgau et al., 1995, 1998]: doxy-
cycline for 10 days; study 3 [Christgau et al., 2002]: amoxicillin or 
clindamycin for 2 days). During the first 6 post-operative weeks, 
all patients had to suspend mechanical oral hygiene procedures 
in the area of surgery, rinse with 0.2% chlorhexidine solution and 
undergo weekly inspections including tooth cleaning. All patients 
were scheduled in a strict supportive periodontal therapy (SPT) 
programme at the Department of Conservative Dentistry and 
Periodontology of the University Hospital Regensburg for the first 
post-operative year with visits every 2–3 months. After that pe-
riod, patients were encouraged to further participate in this SPT 
programme but most of them returned to their referring dentists. 
The remaining patients were scheduled for SPT twice a year in 
the undergraduate programme of the Department of Conservative 
Dentistry and Periodontology.
2.4 | Clinical examinations
The clinical examinations of this follow-up study were performed 
by two blinded examiners (FC; AP), who had previously been cali-
brated to the principal investigator (MC). The examiners were not 
involved in the treatments and not aware of the treatment mo-
dality used in the individual defects. Oral hygiene was assessed 
by the approximal plaque index (API; Lange, Plagmann, Eenboom, 
& Promesberger, 1977) and gingival inflammation by the papillary 
bleeding index (PBI; Saxer & Mühlemann, 1975). The following 
clinical parameters were recorded for the assessment of the peri-
odontal situation using a PCP-UNC-15 periodontal probe (PCP-
UNC-156; Hu-Friedy): gingival recession (REC) as the distance 
between the cemento-enamel junction (CEJ) or the cervical mar-
gin of a restauration to the gingival margin, probing pocket depth 
(PPD) as the distance from the gingival margin to the fundus of a 
periodontal pocket, and clinical attachment level (CAL) as the dis-
tance from the CEJ or the cervical margin of a restauration to the 
fundus of a periodontal pocket. Furthermore, bleeding on probing 
(BOP) was recorded. In addition, the vertical relative attachment 
gain (V-rAG) was calculated as the percentage of the CAL gain re-
lated to the baseline depth of the osseous defect measured intra-
operatively (Christgau et al., 1995, 1998, 2002). Furthermore, the 
total number of residual teeth at this follow-up was recorded for 
each patient.
Apart from the clinical parameters, a detailed anamnesis of the 
medical history of the individual patient was obtained, with particu-
lar emphasis on the aspects of smoking habits and history of diabe-
tes mellitus. Smoking habits were recorded as pack-years. History 
of diabetes comprised both type I and type II diabetes. However, 
there were no data available on the quality of metabolic control 
during this long period of time. The timepoint of a possible loss of 
a treated tooth was obtained either from the dental charts or by 
interview of the respective patient. Furthermore, the frequency 
of SPT participation was examined based on the dental charts (for 
individuals still being patients at the University Hospital) or the 
self-reported information provided by the patients. SPT participa-
tion at least twice per year (irrespective of the SPT provider) was 
classified as “regular SPT.”
2.5 | Data analysis
The single defect was regarded as statistical unit in this study. As 
discussed previously (Christgau, Schmalz1, Wenzel, & Hiller, 1997), 
clinical measurements are reported as median values (with 1st and 
3rd quartiles) and were statistically evaluated using chi-square tests 
and non-parametric Mann–Whitney tests on a significance level 
of α = 0.05. The Kaplan–Meier procedure was applied for survival 
analysis followed by log-rank tests for determining significant dif-
ferences between survival curves (α = 0.05). All statistical analyses 
were performed using SPSS for Windows, version 25 (SPSS Inc.).
3  | RESULTS
For inclusion in this follow-up study, patients had to have re-
ceived the intended treatment and successfully completed clinical 
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F I G U R E  1   Flowchart of the study outline
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examinations at baseline as well as after 1 year. Therefore, 2 out of 
the initially recruited 74 patients had to be excluded due to missing 
baseline or 1-year data. Further 22 patients could not be re-exam-
ined because the surgical site either did not correspond to the inclu-
sion criteria of this study with regard to defect classification (i.e. no 
furcation involvement) or the patient was not available.
From the remaining 50 patients contributing 102 surgical sites, 
34 (contributing 69 surgical sites) could be scheduled for clini-
cal examination at the Department of Conservative Dentistry and 
Periodontology of the University Hospital Regensburg, while the 
other 16 patients (contributing 33 surgical sites) were only available 
for an oral interview by telephone. Consequently, tooth survival 
analyses could be performed in 102 surgical sites in 50 patients. 
Figure 1 shows the flow of participants through the stages of this 
study. Table 1 gives an overview of the patients and defects that 
were available for this follow-up.
3.1 | Compliance with SPT
The calculation of the SPT frequencies was carried out based on 
the dental charts (for individuals still being patients at the University 
Hospital) and the information provided by the 50 patients who were 
available for tooth survival analysis. After the first post-operative year, 
40.2% of all surgical sites received SPT only at the University Hospital, 
13.7% only at their referring dentists and 46.1% alternating between 
the University Hospital and the referring dentists. 53.9% of the surgical 
sites received SPT at least twice a year (irrespective of the SPT provider), 
while 46.1% of the surgical sites received SPT less than twice a year.
3.2 | Tooth survival analysis
Tooth survival analysis was performed in 50 patients contributing 
102 surgical sites. Up to 26 years after GTR therapy, 52.9% of the 
teeth were still in situ, while 47.1% had been extracted (Figure 2). 
Table 2 shows a frequency distribution of all included teeth with re-
gard to tooth type and CAL at baseline. 19 patients did not lose any 
of the treated teeth, whereas 16 patients lost at least one tooth, 
and 15 patients lost all treated teeth. The median (1st; 3rd quartile) 
duration of tooth survival was found to be 23.4 (21.9; 23.8) years for 
teeth which were still in situ at this follow-up examination and 13.8 
(6.2; 17.2) years for extracted teeth.
When classifying the defects according to tooth-related and 
site-specific factors, there was a tendency for more tooth loss in pre-
molars (p = .132) and molars (p = .105) as compared to anterior teeth 
(Figure 3a) and in initially deeper defects with CAL ≥ 12 mm at baseline 
as compared to defects with CAL ≤ 8 mm (p = .08) or CAL 9–11 mm 
(p = .078; Figure 3b). Considering the 1-year data, there was significantly 
more tooth loss in surgical sites still exhibiting CAL ≥ 7 mm at 1 year as 
compared to surgical sites with CAL ≤ 4 mm (p = .045) and CAL 5–6 mm 
(p = .043; Figure 3c). Furthermore, there was a tendency for more tooth 
loss in surgical sites with residual PPD ≥ 6 mm at 1 year as compared 
to sites with 1-year PPD ≤ 3 mm and 1-year PPD 4–5 mm (Figure 3d).
Taking patient-related factors into account, that is age at baseline 
(Figure 4a), history of diabetes (Figure 4b), smoking habits (Figure 4c) 
and frequency of SPT participation between 1 and 26 years after GTR 
therapy (Figure 4d), there was significantly more tooth loss in diabetic 
patients as compared to non-diabetics and in patients with smoking 
history of at least 10 pack-years as compared to non-smokers and 
patients with smoking history of less than 10 pack-years. In diabetic 
patients, only 20% of the treated teeth were still in situ, whereas in 
non-diabetics 61% of the treated teeth were still in situ (p = .001). In 
non-smokers, 57.5% of the treated teeth could be preserved, while in 
smokers with history of at least 10 pack-years only 25% of the treated 
teeth were still in situ (p = .011). There was a slight tendency for more 
tooth loss in patients with an age of at least 51 years at baseline com-
pared to the younger patient groups. On the contrary, no statistically 
significant association could be found between tooth loss and fre-
quency of SPT participation between 1 and 26 years.
Additionally, the total number of residual teeth at the long-term fol-
low-up was recorded in 44 patients contributing 89 surgical sites. GTR-
treated teeth, which were still in situ, were accompanied by 25 (18.8; 
27) residual teeth in median (1st; 3rd quartile), while sites, where the 
GTR-treated tooth was lost, were accompanied by only 12 (4; 21) re-
sidual teeth. This difference was found statistically significant (p = .000).
3.3 | Clinical examinations
Clinical examinations could be performed in 34 patients, originally 
contributing 69 defects, which showed a median (1st; 3rd quartile) 
TA B L E  1   Numbers of patients and defects available for this follow-up from each original study and the respective follow-up durations
 
Study 1
Christgau et al. (1995)
Study 2
Christgau et al. (1998)
Study 3
Christgau et al. (2002) Total
Patients
N
8 18 24 50
Defects
n
16 38 48 102
Years of follow-up
median
(min; max)
25.4
(25.2; 26.2)
23.5
(23.1; 24.5)
21.8
(21.3; 22.3)
23.3
(21.3; 26.2)
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API of 33% (20%; 44%). Table 3 reports the clinical periodontal data 
for teeth still in situ as well as for the extracted teeth. Furthermore, 
the respective changes of periodontal parameters after 1 and up to 
26 years are reported.
The median baseline PPD was 8.0 mm (in situ) or 9.0 mm (ex-
tracted) and decreased to 4.0 mm or 5.0 mm, respectively, after 
1 year. After up to 26 years, no increase in PPD was found for the 
teeth that were still in situ. Median baseline REC of teeth still in situ 
was 1.5 mm and increased to 2.0 mm after 1 year and 3.0 mm after 
up to 26 years. In contrast, median REC of extracted teeth was found 
constant at 2.0 mm at baseline and the 1-year follow-up. The me-
dian baseline CAL was 9.0 mm (in situ) or 10.0 mm (extracted), both 
exhibiting a significant CAL gain of 3.0 mm resulting in 6.0 mm (in 
situ) or 7.0 mm (extracted) at the 1-year examination. For the teeth 
found still in situ, there was no median change in CAL between the 
1-year examination and the follow-up after up to 26 years. The clin-
ical 1-year data differed statistically significantly between the teeth 
still in situ and those extracted over time in median PPD (p = .03), 
median REC (p = .008) and median CAL (p = .022). The median V-rAG 
was found 66.7% (in situ) and 60.0% (extracted) between baseline 
and 1 year, and 57.1% in the in situ-group between baseline and the 
follow-up after up to 26 years.
4  | DISCUSSION
There are only very few studies reporting on long-term outcomes 
after regenerative periodontal therapies, as it was recently con-
cluded by Wu et al. (2017) in their systematic review. With regard to 
GTR (or combined GTR/graft therapy) in intra-bony defects, there 
are only five studies with follow-up periods of 10 years (Nickles, 
Ratka-Krüger, Neukranz, Raetzke, & Eickholz, 2009; Nygaard-
Østby, Bakke, Nesdal, Susin, & Wikesjö, 2010; Pretzl, Kim, Holle, 
& Eickholz, 2008; Pretzl et al., 2009; Sculean et al., 2008), one 
study with 13-year follow-up evaluating additional application 
of autogenous platelet concentrate (Cieplik et al., 2018) and two 
studies with follow-up periods of 20 years (Cortellini et al., 2017; 
Petsos et al., 2019). These latter two studies are prospective clini-
cal studies comparing GTR therapy and open flap debridement 
(OFD) but comprise only 41 defects (in 41 patients; parallel design; 
Cortellini et al., 2017) or 38 defects (in 12 patients; split-mouth 
design; Petsos et al., 2019), respectively. In the present study, pa-
tients from three prospective randomized clinical trials (Christgau 
et al., 1995, 1998, 2002), which each originally had been designed 
to compare clinical healing outcomes of two different types of 
barrier membranes in a split-mouth approach, have been pooled 
to conduct a long-term follow-up investigation of up to 26 years 
(median follow-up duration 23.3 years) after GTR therapy. A com-
mon drawback of long-term studies with follow-up periods of 20 
or even more years is that only parts of the initial patient popula-
tions are still available due to non-avoidable drop outs (e.g., move 
and death). Therefore, in the present study the split-mouth de-
sign of the original studies and the comparison between different 
F I G U R E  2   Results of tooth survival analysis: cumulative survival 
(thick lines) including 95% confidence limits (hairlines) of all surgical 
sites included in this study, irrespective of all other parameters
Time under risk [years]
  Total In situ Extracted
Tooth type Incisors, canines 21
20.6%a 
15
71.4%b 
6
28.6%b 
Premolars 35
34.3%a 
17
48.6%b 
18
51.4%b 
Molars 46
45.1%a 
22
47.8%b 
24
52.2%b 
CAL at baseline ≤8 mm 27
26.5%a 
16
59.3%b 
11
40.7%b 
9–11 mm 47
46.1%a 
27
57.4%b 
20
42.6%b 
≥12 mm 28
27.5%a 
11
39.3%b 
17
60.7%b 
aPercentages of the respective tooth types or CAL at baseline categories. 
bPercentages of in situ or extracted teeth within the respective tooth type or CAL at baseline 
category. 
TA B L E  2   Frequency distribution of 
102 surgical sites in 50 patients according 
to tooth type and CAL at baseline with 
regard to whether teeth were still in situ 
after up to 26 years or had been extracted
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membrane types were not followed anymore, particularly as none 
of the three original studies had found significant differences in 
clinical parameters between the respective membrane types in-
vestigated (Christgau et al., 1995, 1998, 2002). Instead, the focus 
of the present study was set on tooth survival and clinical long-
term stability, independent of the respective type of barrier mem-
brane used. Therefore, not the individual patient but the single 
surgical site was chosen as statistical unit for this study. Since 
patients contributed different numbers of defects, dependencies 
among the surgical sites in one patient cannot be excluded. The 
authors are aware of this problem, but accepted it in order to not 
further reduce the numbers of surgical sites for this long-term 
follow-up.
Tooth survival could be assessed in 102 surgical sites (in 50 
patients), and clinical examinations were possible in 69 surgical 
sites (in 34 patients). Although the present study lacks an OFD 
control group, it reports the longest follow-up after GTR therapy 
with the largest number of re-examined surgical sites in the liter-
ature, so far.
4.1 | Compliance with SPT
Regular participation in a SPT programme is known to be cru-
cial for long-term success of periodontal treatment (Axelsson & 
Lindhe, 1978; Axelsson, Nyström, & Lindhe, 2004; Mombelli, 2019) 
and particularly of regenerative periodontal therapy (Cortellini, 
Prato, & Tonetti, 1996; Cortellini & Tonetti, 2004). All patients in-
cluded in this follow-up had participated in a strict SPT programme 
at the University Hospital within the first post-operative year. Due 
to the wide catchment area of the University Hospital Regensburg 
and the geographical context of the Oberpfalz Region, many pa-
tients subsequently preferred to attend their referring local dentists 
rather than to accept long distances and shoulder additional travel 
costs to reach Regensburg. Furthermore, the principal investigator, 
who had performed all surgical procedures (MC), left the University 
Hospital Regensburg in 2002, which may further have deteriorated 
patients’ adherence, whereas Cortellini et al. showed that a high 
degree of SPT adherence can be achieved, if patients are treated by 
the same dentist over a long period of time (Cortellini et al., 2017). 
F I G U R E  3   Results of tooth survival analysis: cumulative survival (thick lines) including 95% confidence limits (hairlines) of all surgical sites 
included in this study grouped according to tooth-related factors: tooth type (a), CAL at baseline (b), CAL at 1-year (c) and PPD at 1-year (d), 
irrespective of all other parameters. Asterisks depict statistically significant differences (p < .05) between survival curves
(a) (b)
(c) (d)
 8 mm 
9-11 mm 
 12 mm
Incisors, canines 
Premolars 
Molars
Time under risk [years] Time under risk [years]
CAL at baseline
Time under risk [years] Time under risk [years]
 4 mm 
5-6 mm 
 7 mm
CAL at 1-year
 3 mm 
4-5 mm 
 6 mm
PPD at 1-year
*
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All in all, only 53.9% of the surgical sites received at least two SPT 
appointments per year (including periodontal examinations and 
supra- and subgingival tooth cleaning) over the whole examination 
period of up to 26 years. However, these data are at least partly 
based on the information provided by the patients. Although big 
efforts were made for a detailed and thorough questioning of the 
patients, the self-reported data could not be controlled and thus 
must be interpreted with some caution. Petsos et al. also described 
that their patients were not permanently kept in regular SPT dur-
ing their 20-year follow-up (Petsos et al., 2019). On the contrary, 
Cortellini et al. (2017) reported that their patients received SPT in 
a specialist practice with appointments every three months and 
that 41 out of 45 patients complied with this programme for more 
than 20 years. Such good compliance with SPT protocols is highly 
desirable after periodontal therapy, particularly following regen-
erative periodontal procedures such as GTR, but may not be gener-
ally realizable (Elangovan, 2016). Accordingly, two recent reviews 
pointed out that the adherence to SPT is highly variable with only 
about 30% of the patients following the recommended SPT regi-
mens in the long term (Amerio et al., 2020; Echeverría, Echeverría, 
& Caffesse, 2019).
4.2 | Tooth survival analysis
As suggested by Hujoel et al., true end points like tooth loss should 
be used for evaluating periodontal treatment approaches (Hujoel, 
Armitage, & García, 2000). In this study, 52.9% of the initially heav-
ily diseased teeth were still in situ at the follow-up examination up 
to 26 years after GTR therapy. This stands in marked contrast to 
Cortellini et al. who described that all teeth that had received GTR 
therapy were still in function after 20 years (Cortellini et al., 2017) and 
to Petsos et al. who reported a 20-year tooth survival of about 79% 
in the sites treated with GTR (Petsos et al., 2019). This difference may 
be attributed to several factors: as outlined above, only about half 
of the defects included here received SPT with at least two regular 
F I G U R E  4   Results of tooth survival analysis: cumulative survival (thick lines) including 95% confidence limits (hairlines) of all surgical sites 
included in this study grouped according to patient-related factors: age at baseline (a), history of diabetes mellitus (b), smoking habits (c) and 
SPT frequency between 1 and up to 26 years (d), irrespective of all other parameters. Asterisks depict statistically significant differences 
(p < .05) between survival curves
Non-smokers 
Smokers (< 10 pack years) 
Smokers (  10 pack years)
 40 years 
41-50 years 
 51 years
Age at baseline
Non-diabetics 
Diabetics
 2 per year 
< 2 per year
SPT frequency
*
*
Time under risk [years]
Time under risk [years] Time under risk [years]
Time under risk [years]
(a) (b)
(c) (d)
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recall appointments per year over the whole study period. The lack of 
a clear association between tooth loss and irregular SPT participation 
found here may be attributed to the at least partially self-reported 
data from the patients and a potentially insufficient quality of SPT 
provided by the referring dentists which both could not be controlled 
by the investigators. Accordingly, tooth survival was found slightly 
higher for patients who continuously received SPT at the University 
Hospital, which did not reach the level of statistical significance (data 
not shown). Therefore, besides the fact that teeth with very deep de-
fects were treated, the consistent loss of teeth observed in this study 
may be at least partly attributed to the irregular and probably insuf-
ficient SPT over this long study period.
Another aspect may be the higher proportion of molars (46.2%) 
in the present study as compared to both other studies (about 11% 
or 32% of teeth treated with GTR for Cortellini et al. (2017) or Petsos 
et al. (2019), respectively). Accordingly, when evaluating tooth sur-
vival with regard to the site-specific factor tooth type and CAL at 
baseline, there was a trend for higher tooth loss in premolars and 
molars and defects with higher CAL at baseline. Helal et al. also re-
ported significantly higher risk of tooth loss for molars (odds ratio 
(OR): 4.22, 95% confidence intervals (CI): 2.12–8.39) and teeth with 
high PPD (OR: 3.19; 95% CI: 1.7–5.98) in their systematic review on 
predictors of tooth loss in periodontitis patients (Helal et al., 2019). 
Multi-rooted teeth may be, in general, more prone to periodontal 
disease due to potential furcation involvement, but also may have 
higher risk for endodontic complications and may be more heav-
ily restored as compared to single-rooted teeth (Helal et al., 2019). 
When stratifying according to the 1-year data, we also found sig-
nificantly less tooth survival in teeth still showing CAL ≥ 7 mm and a 
tendency for less tooth survival in teeth with a residual PPD ≥ 6 mm 
after 1 year. Thus, surgical sites which did not optimally respond to 
GTR therapy and still exhibited persistent pockets 1 year after sur-
gery had a higher risk for tooth loss.
When evaluating tooth survival according to patient-related fac-
tors, we found significantly more tooth loss in patients with diabetes 
and in smokers with a history of at least 10 pack-years. This also 
is consistent with Helal et al. who reported significantly higher risk 
of tooth loss for smokers (OR: 1.98; 95% CI: 1.58–2.48) and diabet-
ics (OR: 1.8; 95% CI: 1.26–2.57). Smoking and diabetes are known 
as important risk factors for onset and progression of periodonti-
tis (Knight, Liu, Seymour, Faggion, & Cullinan, 2016; Kocher, König, 
Borgnakke, Pink, & Meisel, 2018; Ryder, Couch, & Chaffee, 2018) 
and have also been included as grade modifiers in the new classifica-
tion of periodontal diseases (Papapanou et al., 2018). There was also 
a slight trend for higher tooth loss in patients with an age of at least 
51 years at baseline. Age has been shown to be a constant risk factor 
for tooth loss in general, particularly due to an impaired ability to 
manage oral hygiene properly with increasing age (Grönbeck Lindén, 
Hägglin, Gahnberg, & Andersson, 2017). With respect to the present 
study, this seems reasonable given the fact that patients aged 51 at 
baseline have now reached their mid-70s.
Interestingly, we found that, if a GTR-treated tooth was still in 
situ, it was accompanied by significantly more residual teeth in the 
respective patient (median 25 teeth) as compared to sites, where the 
GTR-treated tooth was already lost (median 12 teeth). Since many 
patients returned to their referring dentists after the 1-year fol-
low-up, the reasons for extractions are not transparent and may be 
very subjective according to the approach of the respective general 
practitioner.
4.3 | Clinical examinations
As discussed above, a strongly reduced statistical power due to 
non-avoidable drop outs up to 26 years after GTR therapy impeded 
sufficient comparisons between the distinct types of barrier mem-
branes. Therefore, the original split-mouth design of the included 
studies was left for a joint analysis of all defects. The median CAL 
gain obtained 1 year after periodontal surgery measured 4.0 mm 
for defects found still in situ after up to 26 years and 3.0 mm for 
defects that had been extracted in the meanwhile. These results 
are in line with those from previous studies on GTR therapy in 
intra-bony defects (Murphy & Gunsolley, 2003). For teeth still 
in situ after up to 26 years, the median CAL gain was 3.0 mm as 
compared to baseline. Interestingly, there was no new median CAL 
loss between the 1-year examination and this follow-up. However, 
this finding must be interpreted with some caution because only 
a selection of “successful” teeth could be re-examined after up to 
26 years. The large part of failing teeth (probably showing CAL 
loss) was already extracted before this follow-up examination. 
Petsos et al. (2019) recently reported a mean CAL loss of 0.53 mm 
only between their 1-year and their 20-year examination. Likewise, 
Cortellini et al. found mean new CAL losses of 0.1 mm or 0.5 mm 
between 1 and 20 years, depending on the surgical technique 
used (modified papilla preservation technique or access flap, 
respectively).
5  | CONCLUSIONS
Up to 26 years following GTR therapy, 52.9% of the treated teeth 
were still found in situ. The loss of 47.1% of the treated teeth 
may be at least partially attributed to the irregular and probably 
insufficient SPT. Diabetic patients and individuals with smoking 
history of at least 10 pack-years showed statistically significant 
worse tooth survival, while there were also trends for worse tooth 
survival for premolars and molars as well as for defects with base-
line CAL ≥ 12 mm. Teeth that were found still in situ after up to 
26 years exhibited no new median CAL loss as compared to the 
1-year follow-up.
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